Key facts
- This page summarizes John E. Kao's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2024, 17:27.
John E. Kao - 14 Mar 2024 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- ALHC
- Reported as of
- 14 Mar 2024
- Net transaction value
- +$496,779
- SEC form
- 4
- Accepted by SEC
- 18 Mar 2024, 17:27:36 UTC
- Prior SEC filing
- 15 Mar 2024
- Next SEC filing
- 11 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John E. Kao filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 18 Mar 2024.
Change
- Previous filing in this sequence was filed on 15 Mar 2024.
- Current net transaction value: +$496,779.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALHC
transaction
Common Stock
Purchase
- Transaction value
- $496,779
- Shares
- +103,000
- Change %
- +3.9%
- Price
- $4.82
- Shares after
- 2,745,253
- Date
- 14 Mar 2024
- Ownership
- Direct
- Footnotes
- F1, F2
ALHC
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,723,100
- Date
- 14 Mar 2024
- Ownership
- See Footnote
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The transaction reported on this Form 4 is an open-market purchase by the reporting person of 103,000 shares of common stock at a weighted-average purchase price per share of $4.8231.
Footnote F2
The reported price in column 4 is a weighted-average price. Shares were purchased in multiple transactions at a per share price ranging from $4.77 to $4.87. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range.
Footnote F3
Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.